Medtronic nabs 510(k) for combination surgical device

Medtronic ($MDT) has secured the FDA's blessing to market its Aquamantys 3 BSC 9.1S bipolar sealer with cutting, a device that combines two surgical techs in one. Medtronic's instrument features hemostatic sealing capabilities for bone and soft tissue, in addition to blades for cutting. The sealer includes the company's Transcollation technology, using radiofrequency energy and saline to reduce bone loss and keep hemoglobin levels stable, the company said. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.